What should be monitored carefully after initiating Milrinone treatment?

After initiating Milrinone treatment, it is crucial to monitor blood pressure closely. Milrinone is a phosphodiesterase inhibitor that has both inotropic (increases contractility of the heart) and vasodilatory effects. This means that while it helps improve heart function, it can also lead to a decrease in systemic vascular resistance, potentially resulting in lowered blood pressure.

Monitoring blood pressure is essential to ensure that the patient does not develop hypotension, which can be a side effect of this medication. It is important to assess the hemodynamic status frequently during treatment to maintain optimal blood pressure levels and to adjust dosages accordingly if significant changes occur. Maintaining adequate blood pressure will help ensure adequate organ perfusion and prevent further complications in patients with heart failure.

While fluid intake, heart rate, and temperature are also important to monitor in heart failure patients receiving treatment, they do not carry the same immediate risk as blood pressure changes associated with Milrinone therapy.